Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombopoietin Receptor Agonist”

46 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 46 results

Not applicableStudy completedNCT01618734
What this trial is testing

Eltrombopag and Romiplostim Used Alternatively in Patients With Immune Thrombopenia (ITP): Efficacy and Safety.

Who this might be right for
Immune ThrombocytopeniaThrombopoietin Receptor Agonist
Henri Mondor University Hospital 50
Testing effectiveness (Phase 2)Study completedNCT06287567
What this trial is testing

Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP)

Who this might be right for
Idiopathic Thrombocytopenic PurpuraImmune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 17
Testing effectiveness (Phase 2)Study completedNCT00110799
What this trial is testing

SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C

Who this might be right for
Hepatitis C, ChronicHepatitis CThrombocytopenia
GlaxoSmithKline 75
Not applicableLooking for participantsNCT05931718
What this trial is testing

Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia

Who this might be right for
Autoimmune Hemolytic AnemiaImmune ThrombocytopeniaChronic Idiopathic Neutropenia+3 more
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 200
Testing effectiveness (Phase 2)Study completedNCT00908037
What this trial is testing

Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 82
Large-scale testing (Phase 3)Study completedNCT05492409
What this trial is testing

Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients

Who this might be right for
Idiopathic Thrombocytopenic Purpura
AO GENERIUM 160
Post-approval studies (Phase 4)Study completedNCT00888901
What this trial is testing

Platelet Function in Idiopathic Thrombocytopenic Purpura (ITP) Patients With Eltrombopag

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Ingrid Pabinger, MD 30
Testing effectiveness (Phase 2)Study completedNCT00961064
What this trial is testing

A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic SyndromesThrombocytopenia
National Heart, Lung, and Blood Institute (NHLBI) 30
Testing effectiveness (Phase 2)Study completedNCT00922883
What this trial is testing

A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients

Who this might be right for
Anemia, AplasticAnemia, HypoplasticThrombocytopenia
National Heart, Lung, and Blood Institute (NHLBI) 43
Post-approval studies (Phase 4)Study completedNCT01098487
What this trial is testing

A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 167
Large-scale testing (Phase 3)Study completedNCT02201290
What this trial is testing

A Long-term Safety Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Novartis Pharmaceuticals 9
Testing effectiveness (Phase 2)Study completedNCT01890746
What this trial is testing

A Safety and Efficacy Study of Eltrombopag in Subjects With AML

Who this might be right for
Acute Leukaemia
Novartis Pharmaceuticals 148
Testing effectiveness (Phase 2)Active Not RecruitingNCT05885555
What this trial is testing

Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of Therapies

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Novartis Pharmaceuticals 41
Early research (Phase 1)Study completedNCT00358540
What this trial is testing

Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide

Who this might be right for
Thrombocytopaenia
GlaxoSmithKline 18
Not applicableStudy completedNCT02298075
What this trial is testing

Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Gruppo Italiano Malattie EMatologiche dell'Adulto 148
Testing effectiveness (Phase 2)Study completedNCT01168921
What this trial is testing

Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
CLLLeukemia
M.D. Anderson Cancer Center 23
Large-scale testing (Phase 3)Study completedNCT00828750
What this trial is testing

Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Who this might be right for
Idiopathic Thrombocytopenic PurpuraPurpura, Thrombocytopenic, Idiopathic
GlaxoSmithKline 19
Not applicableStudy completedNCT00643929
What this trial is testing

LENS - Long-term Eltrombopag Observational Study

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 164
Post-approval studies (Phase 4)Looking for participantsNCT07133659
What this trial is testing

Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot Study

Who this might be right for
ITP - Immune Thrombocytopenia
Al-Mustansiriyah University 25
Not applicableStudy completedNCT06408324
What this trial is testing

Evaluation of the Use of Thrombopoietin Receptor Agonists in Adults With Primary ITP in Europe

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
European Research Consortium on ITP 275
Load More Results